We are live on ! Find out more
GMDA

Gamida Cell Ltd. Ordinary Shares
GMDA

Delisted

GMDA was delisted on the 5th of April, 2024.

Back to rankings

62 hedge funds and large institutions have $38.3M invested in Gamida Cell Ltd. Ordinary Shares in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

331% more call options, than puts

Call options by funds: $392K | Put options by funds: $91K

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

48% more capital invested

Capital invested by funds: $25.9M → $38.3M (+$12.4M)

42% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 12

9% more funds holding

Funds holding: 57 → 62 (+5)

Holders
62
Holders Change
+5
Holders Change %
+8.77%
% of All Funds
1.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
17
Reduced
12
Closed
6
Calls
$392K
Puts
$91K
Net Calls
+$301K
Net Calls Change
+$395K

Top Buyers

Rank Fund Capital Flow
1
MIH
Meitav Investment House
Israel
+$7.35M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$6.06M
3
KHLMVGHM
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet
Israel
+$5.04M
4
RSCM
Rock Springs Capital Management
Maryland
+$4.43M
5
KHLMTHM
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet
Israel
+$1.83M

Top Sellers

Rank Fund Capital Flow
1
HCM
Highbridge Capital Management
New York
-$2.12M
2
AIM
ARK Investment Management
Florida
-$1.56M
3
Federated Hermes
Federated Hermes
Pennsylvania
-$754K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$277K
5
JP Morgan Chase
JP Morgan Chase
New York
-$235K
Name Holding Trade Value Shares
Change 		Change in
Stake
LCS
26
Levin Capital Strategies
New York
$40K +$57K +25,000 New
Citadel Advisors
27
Citadel Advisors
Florida
$40K +$57.8K +25,350 New
PFO
28
Pathstone Family Office
New Jersey
$34.3K +$24.8K +10,893 +100%
D.E. Shaw & Co
29
D.E. Shaw & Co
New York
$32K -$162K -71,130 -78%
GIM
30
Guild Investment Management
California
$29K – – –
OQS
31
Occudo Quantitative Strategies
Florida
$24K +$34.4K +15,108 New
Stifel Financial
32
Stifel Financial
Missouri
$23K +$1.6K +700 +5%
Creative Planning
33
Creative Planning
Kansas
$19K +$342 +150 +1%
CSS
34
Cubist Systematic Strategies
Connecticut
$18K -$28.3K -12,392 -52%
SSA
35
Schonfeld Strategic Advisors
New York
$18K +$26K +11,400 New
Balyasny Asset Management
36
Balyasny Asset Management
Illinois
$17K +$23.8K +10,424 New
1CM
37
1492 Capital Management
Wisconsin
$16K – – –
Group One Trading
38
Group One Trading
Illinois
$12K -$20.9K -9,181 -55%
Simplex Trading
39
Simplex Trading
Illinois
$12K +$6.51K +2,856 +57%
IFAM
40
Institutional & Family Asset Management
Colorado
$11K – – –
MCM
41
MV Capital Management
Maryland
$11K – – –
TRCT
42
Tower Research Capital (TRC)
New York
$10K -$20.9K -9,188 -59%
Wells Fargo
43
Wells Fargo
California
$10K – – –
TWC
44
TD Waterhouse Canada
Ontario, Canada
$6.44K – – –
US Bancorp
45
US Bancorp
Minnesota
$3K – – –
HIIFS
46
Harel Insurance Investments & Financial Services
Israel
$2K -$176 -77 -6%
AP
47
Atwood & Palmer
Missouri
$2K – – –
IA
48
IFP Advisors
Florida
$2K – – –
PGAM
49
Princeton Global Asset Management
New Jersey
$2K – – –
QT
50
Quantbot Technologies
New York
$2K – – –
1
2
3

GMDA Hedge Fund Activity: Q3 2022 in Review

62 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Gamida Cell Ltd. Ordinary Shares (GMDA) for Q3 2022, worth a combined $38.3M — up 48% from $25.9M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new GMDA positions and 6 closed out — a net gain of 5 holders — while 17 added to existing stakes and 12 trimmed.

The largest buyer was Meitav Investment House, adding an estimated $7.35M. The largest seller was Highbridge Capital Management, exiting entirely with an estimated $2.12M sold.

  • 62 institutional investors held Gamida Cell Ltd. Ordinary Shares (GMDA) as of Q3 2022, up from 57 in Q2 2022.
  • Funds reported $38.3M of Gamida Cell Ltd. Ordinary Shares stock for Q3 2022, up 48% quarter-over-quarter.
  • 11 funds opened new Gamida Cell Ltd. Ordinary Shares positions in Q3 2022 and 6 closed out, a net change of +5 holders.
  • The largest Gamida Cell Ltd. Ordinary Shares buyer in Q3 2022 was Meitav Investment House, an estimated $7.35M added.
  • The largest Gamida Cell Ltd. Ordinary Shares seller in Q3 2022 was Highbridge Capital Management, an estimated $2.12M sold.

Based on aggregated 13F filings for Q3 2022.